Financial Health Assessment: PC INDUSTRIES LTD

1. Financial Health Score: D+

The patient is currently experiencing chronic financial fatigue and acute liquidity stress. While the business is still breathing (operational), its vital signs indicate a heavy reliance on shifting inventory to survive, with financial reserves rapidly depleting over the past two years.

2. Key Vital Signs

Blood Pressure (Liquidity): Dangerously Low * Current Ratio: 0.91 (£38,881 Current Assets / £42,682 Current Liabilities) * Net Current Assets: -£3,801 * Interpretation: The company's short-term debts exceed its short-term assets. Just like a patient with low blood pressure, the business lacks the immediate financial circulation (working capital) to comfortably meet its near-term obligations without selling off stock.

Pulse (Cash Flow): Weak but Present * Cash at Bank: £1,970 (up from a critically low £42 in 2024) * Interpretation: The patient has a pulse, and cash has improved from the prior year, but it remains exceptionally faint relative to the size of the liabilities.

Cholesterol (Asset Congestion): Severely Clogged * Inventory Concentration: 94.9% of current assets (£36,911 out of £38,881) are tied up in stock. * Interpretation: The business's arteries are clogged with inventory. Very little financial fluidity exists; the company is almost entirely dependent on shifting stock to generate cash and pay creditors.

Weight Loss (Equity Erosion): Concerning Wasting * Shareholders' Funds: £6,490 (down from £18,271 in 2023 and £9,655 in 2024) * Retained Earnings: £6,489 (down from £9,654 in 2024) * Interpretation: The patient is losing financial mass rapidly. The drop in retained earnings confirms the business is operating at a loss, effectively haemorrhaging the equity it built up in prior years.

3. Diagnosis

Condition: Acute Inventory Dependency with Chronic Equity Erosion

The financial data reveals a business that is technically insolvent on a current basis (current liabilities exceed current assets). The company is suffering from a severe liquidity blockage; because nearly 95% of its current assets are locked in stock, it cannot quickly access the cash needed to pay its £42,682 in short-term creditors.

Furthermore, the transition from £18,271 in shareholder funds in 2023 to just £6,490 in 2025 is a symptom of significant internal bleeding—specifically, trading losses. The business is burning through its financial reserves to sustain operations. The slight improvement in cash from £42 to £1,970 is a positive sign of basic survival reflexes, but it is insufficient to cure the underlying working capital deficit.

4. Prognosis & Recommendations

Prognosis: Guarded If the company cannot shift its inventory quickly and profitably, it will soon run out of the cash required to pay its creditors, potentially leading to insolvency. However, as an e-commerce retailer (SIC 47910), inventory turnover can be rapid if managed correctly. The business survives on the assumption of going concern, meaning it expects to sell this stock in the normal course of business.

Recommendations (Treatment Plan): 1. Clear the Arteries (Inventory Liquidation): Implement aggressive sales strategies to convert the £36,911 of stock into cash. Consider targeted discounts or promotions. Even at a lower margin, cash in the bank is healthier than stock on the shelf. 2. Blood Transfusion (Cash Injection): The director (who owns over 75% of the business) should consider injecting fresh capital or taking a director's loan to improve the net current asset position and provide a buffer for day-to-day operations. 3. Manage the Blood Pressure (Creditor Negotiation): Open dialogues with suppliers to negotiate extended payment terms. Stretching out liabilities will reduce the immediate pressure on the company's cash flow. 4. Stop the Bleeding (Cost Control): Conduct a thorough review of overheads. The retained earnings are dropping, meaning costs currently exceed revenues. Immediate action is required to align expenses with income.